Conditions: Bipolar I Disorder
Allocation: RANDOMIZED | Intervention model: PARALLEL
Enrollment: 258
Healthy volunteers: no

Brief summary:
The primary objective of this trial is to evaluate the clinical efficacy and safety of aripiprazole in comparison to placebo in patients with Bipolar I Disorder experiencing a manic or mixed episode.

Detailed description:

Arms:
arm 1: None arm 2: None

Interventions: intervention 1: Aripiprazole intervention 2: placebo
Intervention descriptions: intervention 1: oral, 24mg/day intervention 2: oral, 0mg(4tablets)/day

Protocol document: